← Eichor
Condition: Anemia In End Stage Renal Disease Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Anemia In End Stage Renal Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Roxadustat's Effect on Heart, Nutrition, and Inflammation in Hemodialysis Patients
Phase 1/Phase 2 · 1 location(s) · Mansoura University · NCT06903559
Comparing Reticulocyte Hemoglobin and Transferrin Saturation to Guide Iron Treatment in People on Dialysis
NA · 1 location(s) · King Chulalongkorn Memorial Hospital · NCT06906835
Roxadustat for Bone and Neuropsychiatric Aspects in Hemodialysis Patients
Phase 1/Phase 2 · 1 location(s) · Mansoura University · NCT06917950
A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease
Phase 3 · 47 location(s) · Astellas Pharma Global Development, Inc. · NCT05970172
Eculizumab in Hypertensive Emergency-associated Hemolytic Uremic Syndrome
Phase 3 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05726916
Studies on Adsorption International Learning Initiative Global
NA · 1 location(s) · Botkin Hospital · NCT07123909
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.